Dow Jones

39,134.76

0.77%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

RENB

Renovaro (RENB)

Renovaro Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RENB

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
18/06/2024	17:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RENB	Renovaro Inc
14/06/2024	08:06	GlobeNewswire Inc.	Renovaro, Inc. Announces $10 million in Equity Committed	NASDAQ:RENB	Renovaro Inc
11/06/2024	10:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RENB	Renovaro Inc
24/05/2024	15:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RENB	Renovaro Inc
24/05/2024	08:20	GlobeNewswire Inc.	Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	NASDAQ:RENB	Renovaro Inc
17/05/2024	20:37	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:RENB	Renovaro Inc
30/04/2024	10:00	GlobeNewswire Inc.	Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	NASDAQ:RENB	Renovaro Inc
24/04/2024	08:00	GlobeNewswire Inc.	RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership	NASDAQ:RENB	Renovaro Inc
18/04/2024	07:45	GlobeNewswire Inc.	Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Ca	NASDAQ:RENB	Renovaro Inc
23/02/2024	16:01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:RENB	Renovaro Inc
23/02/2024	15:04	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:RENB	Renovaro Inc
22/02/2024	15:17	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:RENB	Renovaro Inc
15/02/2024	08:25	GlobeNewswire Inc.	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace	NASDAQ:RENB	Renovaro Inc
14/02/2024	09:01	GlobeNewswire Inc.	Statement of Renovaro Inc	NASDAQ:RENB	Renovaro Inc
13/02/2024	08:31	GlobeNewswire Inc.	AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine	NASDAQ:RENB	Renovaro Inc
25/01/2024	11:45	GlobeNewswire Inc.	Renovaro Biosciences Announces Results of Special Meeting of Shareholders	NASDAQ:RENB	Renovaro Inc
16/01/2024	07:00	GlobeNewswire Inc.	Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD	NASDAQ:RENB	Renovaro Inc
11/10/2023	08:25	GlobeNewswire Inc.	Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors	NASDAQ:RENB	Renovaro Inc
10/10/2023	07:00	GlobeNewswire Inc.	Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors	NASDAQ:RENB	Renovaro Inc
06/10/2023	15:30	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:RENB	Renovaro Inc
04/10/2023	15:20	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:RENB	Renovaro Inc
02/10/2023	11:05	GlobeNewswire Inc.	Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD	NASDAQ:RENB	Renovaro Inc
02/10/2023	08:28	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:RENB	Renovaro Inc
02/10/2023	08:25	GlobeNewswire Inc.	AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine	NASDAQ:RENB	Renovaro Inc
02/10/2023	06:30	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:RENB	Renovaro Inc
30/09/2023	02:32	Business Wire	GEDi Cube e Renovaro Biosciences siglano un accordo definitivo per realizzare una business combination	NASDAQ:RENB	Renovaro Inc
30/09/2023	02:32	Business Wire	GEDi Cube und Renovaro Biosciences unterzeichnen endgültige Fusionsvereinbarung	NASDAQ:RENB	Renovaro Inc
29/09/2023	16:00	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:RENB	Renovaro Inc
29/09/2023	12:36	Business Wire	GEDi Cube et Renovaro Biosciences signent un accord définitif de fusion	NASDAQ:RENB	Renovaro Inc
29/09/2023	08:15	Business Wire	GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine	NASDAQ:RENB	Renovaro Inc